These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38181066)

  • 1. Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
    Gharpure R; Chard AN; Cabrera Escobar M; Zhou W; Valleau MM; Yau TS; Bresee JS; Azziz-Baumgartner E; Pallas SW; Lafond KE
    PLoS Med; 2024 Jan; 21(1):e1004333. PubMed ID: 38181066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.
    Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR
    Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare personnel acceptance and recommendations for influenza vaccine in twelve low- and middle-income countries: A pooled analysis from 2018 to 2020.
    McCarron M; Marcenac P; Yau TS; Lafond KE; Ebama MS; Duca LM; Sahakyan G; Bino S; Coulibaly D; Emukule G; Khanthamaly V; Zaraket H; Cherkaoui I; Otorbaeva D; Stravidis K; Safarov A; Bettaieb J; Igboh LS; Azziz-Baumgartner E; Vanyan A; Manukyan A; Nelaj E; Preza I; Douba A; N'Gattia A; Tengbriacheu C; Pathammavong C; Alame M; Alj L; Ben Salah A; Lambach P; Bresee JS
    Vaccine; 2024 Oct; 42 Suppl 4(Suppl 4):125670. PubMed ID: 39198045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza cost and cost-effectiveness studies globally--a review.
    Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
    Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the social and economic burden of influenza in low- and middle-income countries.
    de Francisco Shapovalova N; Donadel M; Jit M; Hutubessy R
    Vaccine; 2015 Nov; 33(48):6537-44. PubMed ID: 26597032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh.
    Hassan MZ; Biswas MAAJ; Rahman M; Shoshi HR; Pyash AS; Islam MA; Haque MA; Parvin SR; Hossen MT; Hussain M; Rahman M; Shirin T; Chowdhury F
    BMC Public Health; 2024 Jan; 24(1):242. PubMed ID: 38245668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.
    Breteler JK; Tam JS; Jit M; Ket JC; De Boer MR
    Vaccine; 2013 Oct; 31(45):5168-77. PubMed ID: 24012574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
    Kraigsley AM; Moore KA; Bolster A; Peters M; Richardson D; Arpey M; Sonnenberger M; McCarron M; Lambach P; Maltezou HC; Bresee JS
    Vaccine; 2021 Jun; 39(25):3419-3427. PubMed ID: 33992439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Program cost analysis of influenza vaccination of health care workers in Albania.
    Pallas SW; Ahmeti A; Morgan W; Preza I; Nelaj E; Ebama M; Levin A; Lafond KE; Bino S
    Vaccine; 2020 Jan; 38(2):220-227. PubMed ID: 31669063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
    Imai C; Toizumi M; Hall L; Lambert S; Halton K; Merollini K
    PLoS One; 2018; 13(6):e0198685. PubMed ID: 29879206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
    Edoka I; Kohli-Lynch C; Fraser H; Hofman K; Tempia S; McMorrow M; Ramkrishna W; Lambach P; Hutubessy R; Cohen C
    Vaccine; 2021 Jan; 39(2):412-422. PubMed ID: 33272702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
    Ortega-Sanchez IR; Mott JA; Kittikraisak W; Khanthamaly V; McCarron M; Keokhonenang S; Ounaphom P; Pathammavong C; Phounphenghack K; Sayamoungkhoun P; Chanthavilay P; Bresee J; Tengbriacheu C
    Vaccine; 2021 Dec; 39(52):7633-7645. PubMed ID: 34802790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
    de Fougerolles TR; Baïssas T; Perquier G; Vitoux O; Crépey P; Bartelt-Hofer J; Bricout H; Petitjean A
    BMC Public Health; 2024 May; 24(1):1222. PubMed ID: 38702667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of seasonal influenza vaccination in WHO-defined high-risk populations in Bangladesh.
    Hassan MZ; Jubayer Biswas MAA; Shirin T; Rahman M; Chowdhury F; Azziz-Baumgartner E; Davis WW; Hussain M
    J Glob Health; 2024 Jul; 14():04126. PubMed ID: 39024624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.
    Dawa J; Emukule GO; Barasa E; Widdowson MA; Anzala O; van Leeuwen E; Baguelin M; Chaves SS; Eggo RM
    BMC Med; 2020 Aug; 18(1):223. PubMed ID: 32814581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health economics of rubella: a systematic review to assess the value of rubella vaccination.
    Babigumira JB; Morgan I; Levin A
    BMC Public Health; 2013 Apr; 13():406. PubMed ID: 23627715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.